Bard Associates Inc Harvard Bioscience Inc Transaction History

Bard Associates Inc

$266 Million
Q2 2025

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$0.57 - $2.19 $9,034 - $34,711	-15,850 Reduced 5.92%	251,849 $143,000
Q4 2024 Feb 06, 2025	SELL	$2.02 - $2.82 $90,294 - $126,054	-44,700 Reduced 14.31%	267,699 $564,000
Q3 2024 Nov 06, 2024	BUY	$2.64 - $3.54 $40,666 - $54,530	15,404 Added 5.19%	312,399 $840,000
Q2 2024 Aug 12, 2024	BUY	$2.77 - $4.63 $15,719 - $26,275	5,675 Added 1.95%	296,995 $846,000
Q1 2024 May 13, 2024	BUY	$4.02 - $5.39 $23,709 - $31,790	5,898 Added 2.07%	291,320 $1.24 Million
Q4 2023 Feb 13, 2024	SELL	$4.0 - $5.49 $2,000 - $2,745	-500 Reduced 0.17%	285,422 $1.53 Million
Q3 2023 Nov 13, 2023	SELL	$4.0 - $5.82 $4,000 - $5,820	-1,000 Reduced 0.35%	285,922 $1.23 Million
Q2 2023 Aug 11, 2023	SELL	$4.19 - $6.16 $18,331 - $26,950	-4,375 Reduced 1.5%	286,922 $1.58 Million
Q1 2023 May 12, 2023	SELL	$2.45 - $4.22 $4,900 - $8,440	-2,000 Reduced 0.68%	291,297 $1.22 Million
Q4 2022 Feb 10, 2023	SELL	$2.12 - $2.86 $10,600 - $14,300	-5,000 Reduced 1.68%	293,297 $812,000
Q3 2022 Nov 09, 2022	SELL	$2.33 - $3.92 $932 - $1,568	-400 Reduced 0.13%	298,297 $764,000
Q2 2022 Aug 11, 2022	BUY	$3.28 - $6.42 $27,880 - $54,570	8,500 Added 2.93%	298,697 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $28,665 - $36,810	-4,500 Reduced 1.53%	290,197 $2.05 Million
Q2 2021 Aug 12, 2021	SELL	$5.44 - $8.4 $2,040 - $3,150	-375 Reduced 0.13%	294,697 $2.46 Million
Q1 2021 May 13, 2021	SELL	$3.91 - $6.99 $5,865 - $10,485	-1,500 Reduced 0.51%	295,072 $1.61 Million
Q4 2020 Feb 11, 2021	SELL	$3.0 - $4.5 $450 - $675	-150 Reduced 0.05%	296,572 $1.27 Million
Q3 2020 Nov 12, 2020	SELL	$2.75 - $4.2 $9,762 - $14,910	-3,550 Reduced 1.18%	296,722 $893,000
Q2 2020 Aug 13, 2020	SELL	$2.12 - $3.14 $26,500 - $39,250	-12,500 Reduced 4.0%	300,272 $931,000
Q1 2020 May 13, 2020	BUY	$1.42 - $3.29 $2,343 - $5,428	1,650 Added 0.53%	312,772 $691,000
Q4 2019 Feb 13, 2020	SELL	$2.45 - $3.25 $220,997 - $293,159	-90,203 Reduced 22.48%	311,122 $949,000
Q4 2019 Feb 13, 2020	BUY	$2.45 - $3.25 $219,037 - $290,559	89,403 Added 28.66%	401,325 $2.28 Million
Q3 2019 Nov 14, 2019	SELL	$1.59 - $3.47 $10,454 - $22,815	-6,575 Reduced 2.06%	311,922 $959,000
Q2 2019 Aug 13, 2019	SELL	$1.93 - $4.59 $337 - $803	-175 Reduced 0.05%	318,497 $637,000
Q1 2019 May 13, 2019	SELL	$2.77 - $4.38 $9,141 - $14,454	-3,300 Reduced 1.02%	318,672 $1.37 Million
Q4 2018 Feb 13, 2019	SELL	$3.03 - $5.0 $12,423 - $20,500	-4,100 Reduced 1.26%	321,972 $1.02 Million
Q3 2018 Nov 14, 2018	SELL	$5.0 - $6.65 $15,000 - $19,950	-3,000 Reduced 0.91%	326,072 $1.71 Million
Q2 2018 Aug 15, 2018	SELL	$4.2 - $5.95 $15,540 - $22,015	-3,700 Reduced 1.11%	329,072 $1.76 Million
Q1 2018 May 14, 2018	SELL	$3.3 - $5.15 $48,180 - $75,190	-14,600 Reduced 4.2%	332,772 $1.66 Million
Q4 2017 Feb 13, 2018	SELL	$3.08 - $3.8 $4,620 - $5,700	-1,500 Reduced 0.43%	347,372 $1.15 Million
Q3 2017 Nov 14, 2017	BUY	$2.7 - $3.75 $941,954 - $1.31 Million	348,872	348,872 $1.31 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

22.4M

Call Options Held

79.8K

Put Options Held

11.5K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $20M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.

Account